-
-
-
7 . Academic Journal
Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
- 저자
- by Cahn, Pedro Enrique; Cassetti, Lidia Isabel; Porteiro Barreira, Norma; Angel, Jonathan Benjamin; de Pokomandy, Alexandra, et al.
- 소스
- In The Lancet HIV December 2017 4(12):e536-e546
-
7 . Periodical
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial
- 저자
- by Molina, Jean-Michel; Squires, Kathleen; Sax, Paul E; Cahn, Pedro; Lombaard, Johan, et al.
- 소스
- The Lancet HIV; January 2020, Vol. 7 Issue: 1 pe16-e26, 11p
-
7 . Periodical
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
- 저자
- by Molina, Jean-Michel; Squires, Kathleen; Sax, Paul E; Cahn, Pedro; Lombaard, Johan, et al.
- 소스
- The Lancet HIV; May 2018, Vol. 5 Issue: 5 pe211-e220, 10p
-
7 . Periodical
Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
- 저자
- by Orrell, Catherine; Hagins, Debbie P; Belonosova, Elena; Porteiro, Norma; Walmsley, Sharon, et al.
- 소스
- The Lancet HIV; December 2017, Vol. 4 Issue: 12 pe536-e546, 11p